Press Release Distribution

Filter News

Show All Results

News By Country

None Found

News By Tag

Remove

January 2025
Mo	Su	Sa	Fr	Th	We	Tu
20	19	18	17	16	15	14

Public Company News

Business Press Releases

Marking Press Releases

Topics Locations Industries Dates

	Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP By Corporate Ads NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal Depression
	New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP By Corporate Ads $NRXP: Completion of NDA Filing Expected in First Quarter of 2025

Page updated every 10 minutes

Related Hot
Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP - 913 views New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP - 729 views

Like PRLog?

9K2K1K